202 related articles for article (PubMed ID: 27354153)
21. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
[TBL] [Abstract][Full Text] [Related]
23. Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension.
Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G;
J Thromb Haemost; 2010 Sep; 8(9):1933-42. PubMed ID: 20553388
[TBL] [Abstract][Full Text] [Related]
24. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism.
Le Gal G; Righini M; Roy PM; Sanchez O; Aujesky D; Perrier A; Bounameaux H
Arch Intern Med; 2006 Jan; 166(2):176-80. PubMed ID: 16432085
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
26. Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism?
Wu C; Bates SM
Pol Arch Med Wewn; 2009 Apr; 119(4):225-30. PubMed ID: 19413181
[TBL] [Abstract][Full Text] [Related]
27. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
[TBL] [Abstract][Full Text] [Related]
28. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry.
Avnery O; Martin M; Bura-Riviere A; Barillari G; Mazzolai L; Mahé I; Marchena PJ; Verhamme P; Monreal M; Ellis MH;
J Intern Med; 2020 Jan; 287(1):32-41. PubMed ID: 31394000
[TBL] [Abstract][Full Text] [Related]
29. Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis.
Bruinstroop E; Klok FA; Van De Ree MA; Oosterwijk FL; Huisman MV
J Thromb Haemost; 2009 Apr; 7(4):611-8. PubMed ID: 19175498
[TBL] [Abstract][Full Text] [Related]
30. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2011 May; 105(5):837-45. PubMed ID: 21359409
[TBL] [Abstract][Full Text] [Related]
31. Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism.
Cosmi B; Palareti G
Thromb Res; 2010 Apr; 125 Suppl 2():S62-5. PubMed ID: 20434008
[TBL] [Abstract][Full Text] [Related]
32. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
Shrivastava S; Ridker PM; Glynn RJ; Goldhaber SZ; Moll S; Bounameaux H; Bauer KA; Kessler CM; Cushman M
J Thromb Haemost; 2006 Jun; 4(6):1208-14. PubMed ID: 16706961
[TBL] [Abstract][Full Text] [Related]
33. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
34. Does age-adjusted D-Dimer have a role in assessment of VTE recurrence rates?
Robertson C; Milne D; Watson H
Int J Lab Hematol; 2020 Aug; 42(4):450-452. PubMed ID: 32359031
[TBL] [Abstract][Full Text] [Related]
35. Impact and clinical significance of recurrent venous thromboembolism.
Labropoulos N; Spentzouris G; Gasparis AP; Meissner M
Br J Surg; 2010 Jul; 97(7):989-99. PubMed ID: 20632262
[TBL] [Abstract][Full Text] [Related]
36. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
37. The benefit of D-Dimer testing to decide on stopping anticoagulation after a first unprovoked VTE: a matter of sex or of test sensitivity?
Czihal M; Reinecke H
Vasa; 2015 Sep; 44(5):399. PubMed ID: 26317262
[No Abstract] [Full Text] [Related]
38. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
39. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
[TBL] [Abstract][Full Text] [Related]
40. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
